Year: 2020
Type: article
Abstract: Coronavirus Disease-2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Various studies exist about the molecular mechanisms of viral infection. However, such information is spread across many publications and it is very time-consuming to integrate, and exploit. We develop CoVex, an interactive online platform for SARS-CoV-2 host interactome exploration and drug (target) identification. CoVex integrates virus-human protein interactions, human protein-protein interactions, and drug-target interactions. It allows visual exploration of the virus-host interactome and implements systems medicine algorithms for network-based prediction of drug candidates. Thus, CoVex is a resource to understand molecular mechanisms of pathogenicity and to prioritize candidate therapeutics. We investigate recent hypotheses on a systems biology level to explore mechanistic virus life cycle drivers, and to extract drug repurposing candidates. CoVex renders COVID-19 drug research systems-medicine-ready by giving the scientific community direct access to network medicine algorithms. It is available at https://exbio.wzw.tum.de/covex/.
Source: Nature Communications
Authors: Sepideh Sadegh, Julian Matschinske, David B. Blumenthal, Gihanna Galindez, Tim Kacprowski, Markus List, Reza Nasirigerdeh, Mhaned Oubounyt, Andreas Pichlmair, Tim Daniel Rose, Marisol Salgado-Albarrán, Julian Späth, Alexey Stukalov, Nina K. Wenke, Kevin Yuan, Josch K. Pauling, Jan Baumbach
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,380
Awards: G1682698083, An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes, G4564877243, G4818956955, G4983211463, Sys_CARE - Systemmedizinische Untersuchung alternativer Spleißung bei Herz- und Nierenkrankheiten, Multi-Omics Netzwerkanalyse, München, SyMBoD - Systemmedizinische Analysen zur personalisierten Behandlung von Knochendefekten in Patienten mit Diabetes - Tiermodell, Biobanken und Modellierung, SyMBoD - Systemmedizinische Analysen zur personalisierten Behandlung von Knochendefekten in Patienten mit Typ-2-Diabetes - Biomarker und Systemmedizinische Plattform, G7683572603, G779867698, G8347047309, G8725655327
OpenAlex ID: W3043379468
